These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2423807)

  • 1. Antihypertensive therapy with indoramin in the elderly.
    Deitch MW; Allen IE; Pascucci VL
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S88-92. PubMed ID: 2423807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive effects of indoramin and prazosin in combination with hydrochlorothiazide.
    Solomon R
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S56-62. PubMed ID: 2423799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive therapy with indoramin: risk-benefit profile in clinical practice.
    Stannard M; Cohen M; Marrott PK; Pascucci VL
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S48-52. PubMed ID: 2423797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effect of indoramin and prazosin on blood pressure and lipid profiles in essential hypertension.
    Overlack A; Stumpe KO
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S53-5. PubMed ID: 2423798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind study comparing indoramin and propranolol in the treatment of black patients with hypertension.
    Bennett JM; Weich DJ; Schoeman HS
    S Afr Med J; 1988 Dec; 74(12):619-21. PubMed ID: 3061032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertension.
    Marshall AJ; Kettle MA; Barritt DW
    Br J Clin Pharmacol; 1980 Sep; 10(3):217-21. PubMed ID: 7437237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind comparison of indoramin and pindolol added to hydrochlorothiazide for the treatment of mild to moderate hypertension.
    Luomanmäki K; Hartikainen M
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S63-7. PubMed ID: 2423800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive therapy in the Federal Republic of Germany: clinical practice experience with indoramin (Wydora).
    Grube E; Giesing M
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S43-7. PubMed ID: 2423796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double blind evaluation of indoramin and methyldopa in thiazide treated hypertensive patients.
    Yajnik VH; Patel SC
    Indian Heart J; 1978; 30(1):51-6. PubMed ID: 359454
    [No Abstract]   [Full Text] [Related]  

  • 10. [Open study on the effect and side effects of indoramin, used at the 2d and 3d therapeutic step in essential hypertension].
    Hitzenberger G; Korn A
    Wien Med Wochenschr; 1985 Sep; 135(17):425-30. PubMed ID: 4060742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indoramin as second step therapy in the management of benign essential hypertension.
    Montenero AS; Mazzari M; Schiavoni G; Manzoli U; Gherardi S
    Pharmatherapeutica; 1983; 3(6):417-21. PubMed ID: 6353433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indoramin as an antihypertensive agent in the treatment of essential hypertension. A multicentre trial.
    Bednarek MR; Schoeman HS
    S Afr Med J; 1983 Mar; 63(11):398-400. PubMed ID: 6338603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indoramin in the treatment of hypertension. A mini-review and update.
    Archibald JL; Turner P
    S Afr Med J; 1983 Feb; 63(9):307-9. PubMed ID: 6338605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases.
    Holmes B; Sorkin EM
    Drugs; 1986 Jun; 31(6):467-99. PubMed ID: 3525084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indoramin in the hypertensive diabetic patient.
    Sood VP; Stannard M; Beastall G; Weir RJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S80-3. PubMed ID: 2423805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparison of indoramin and propranolol in the treatment of moderate to severe essential hypertension.
    Antani J; Buckle JW; Turner J; Cohen M
    Curr Med Res Opin; 1983; 8(9):603-11. PubMed ID: 6365463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of indoramin and methyldopa in hypertension.
    Rosendorff C
    S Afr Med J; 1976 May; 50(20):764-8. PubMed ID: 779054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indoramin and prazosin as adjuncts to beta adrenoceptor blockade in hypertension.
    Stokes GS; Frost GW; Graham RM; MacCarthy EP
    Clin Pharmacol Ther; 1979 Jun; 25(6):783-9. PubMed ID: 36250
    [No Abstract]   [Full Text] [Related]  

  • 19. Indoramin in the treatment of hypertension: a placebo controlled trial.
    Ramirez J
    Curr Med Res Opin; 1976; 4(3):177-84. PubMed ID: 780059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of indoramin therapy on BP, renal function, and body fluid composition.
    Bauer JH; Jones LB; Gaddy P
    Arch Intern Med; 1984 Feb; 144(2):308-12. PubMed ID: 6696567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.